These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 29408653

  • 1. Novel carbazole sulfonamide microtubule-destabilizing agents exert potent antitumor activity against esophageal squamous cell carcinoma.
    Niu F, Liu Y, Jing Z, Han G, Sun L, Yan L, Zhou L, Wu Y, Xu Y, Hu L, Zhao X.
    Cancer Lett; 2018 Apr 28; 420():60-71. PubMed ID: 29408653
    [Abstract] [Full Text] [Related]

  • 2. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
    Qiu F, Liu L, Lin Y, Yang Z, Qiu F.
    Anticancer Agents Med Chem; 2019 Apr 28; 19(8):1021-1028. PubMed ID: 30848215
    [Abstract] [Full Text] [Related]

  • 3. YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.
    Cai D, Qiu Z, Yao W, Liu Y, Huang H, Liao S, Luo Q, Xie L, Lin Z.
    Cancer Chemother Pharmacol; 2016 Jun 28; 77(6):1217-29. PubMed ID: 27107592
    [Abstract] [Full Text] [Related]

  • 4. Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma.
    Wang J, Zhang Z, Che Y, Yuan Z, Lu Z, Li Y, Wan J, Sun H, Chen Z, Pu J, He J.
    Cancer Chemother Pharmacol; 2018 Mar 28; 81(3):469-481. PubMed ID: 29308536
    [Abstract] [Full Text] [Related]

  • 5. Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE2.
    Pun IH, Chan D, Chan SH, Chung PY, Zhou YY, Law S, Lam AK, Chui CH, Chan AS, Lam KH, Tang JC.
    Cancer Res Treat; 2017 Jan 28; 49(1):219-229. PubMed ID: 27456944
    [Abstract] [Full Text] [Related]

  • 6. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin.
    Wang F, Ding X, Wang T, Shan Z, Wang J, Wu S, Chi Y, Zhang Y, Lv Z, Wang L, Fan Q.
    PLoS One; 2017 Jan 28; 12(4):e0174276. PubMed ID: 28406985
    [Abstract] [Full Text] [Related]

  • 7. Isoliquiritigenin Suppressed Esophageal Squamous Carcinoma Growth by Blocking EGFR Activation and Inducing Cell Cycle Arrest.
    Ye L, Zhang J, Zhang Y, Gu B, Zhu H, Mao X.
    Biomed Res Int; 2020 Jan 28; 2020():9259852. PubMed ID: 32190688
    [Abstract] [Full Text] [Related]

  • 8. Pseudolaric Acid B Inhibits Proliferation, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma Through Regulating CD147.
    Yin Z, Cai H, Wang Z, Jiang Y.
    Drug Des Devel Ther; 2020 Jan 28; 14():4561-4573. PubMed ID: 33149553
    [Abstract] [Full Text] [Related]

  • 9. Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal squamous cell carcinoma.
    Shen LY, Zhou T, Du YB, Shi Q, Chen KN.
    Cancer Sci; 2019 May 28; 110(5):1735-1745. PubMed ID: 30844117
    [Abstract] [Full Text] [Related]

  • 10. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
    Jing C, Li X, Zhou M, Zhang S, Lai Q, Liu D, Ye B, Li L, Wu Y, Li H, Yue K, Chen P, Yao X, Wu Y, Duan Y, Wang X.
    Theranostics; 2021 May 28; 11(12):5847-5862. PubMed ID: 33897885
    [Abstract] [Full Text] [Related]

  • 11. Chlorogenic acid inhibits esophageal squamous cell carcinoma growth in vitro and in vivo by downregulating the expression of BMI1 and SOX2.
    Zhan Y, Li R, Feng C, Li X, Huang S, Wang L, Liu Z, Jiang J, Han Y.
    Biomed Pharmacother; 2020 Jan 28; 121():109602. PubMed ID: 31707349
    [Abstract] [Full Text] [Related]

  • 12. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
    Bolidong D, Domoto T, Uehara M, Sabit H, Okumura T, Endo Y, Nakada M, Ninomiya I, Miyashita T, Wong RW, Minamoto T.
    Sci Rep; 2020 Jul 16; 10(1):11807. PubMed ID: 32678196
    [Abstract] [Full Text] [Related]

  • 13. PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.
    Furukawa H, Makino T, Yamasaki M, Tanaka K, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y.
    Cancer Sci; 2018 Feb 16; 109(2):412-421. PubMed ID: 29168598
    [Abstract] [Full Text] [Related]

  • 14. A multi-kinase inhibitor APG-2449 enhances the antitumor effect of ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition.
    Luo QY, Zhou SN, Pan WT, Sun J, Yang LQ, Zhang L, Qiu MZ, Yang DJ.
    Biochem Pharmacol; 2021 Jan 16; 183():114318. PubMed ID: 33159967
    [Abstract] [Full Text] [Related]

  • 15. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
    Sugase T, Takahashi T, Serada S, Nakatsuka R, Fujimoto M, Ohkawara T, Hara H, Nishigaki T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Kishimoto T, Mori M, Doki Y, Naka T.
    Int J Cancer; 2017 Jun 01; 140(11):2608-2621. PubMed ID: 28233302
    [Abstract] [Full Text] [Related]

  • 16. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
    Jiang YY, Jiang Y, Li CQ, Zhang Y, Dakle P, Kaur H, Deng JW, Lin RY, Han L, Xie JJ, Yan Y, Doan N, Zheng Y, Mayakonda A, Hazawa M, Xu L, Li Y, Aswad L, Jeitany M, Kanojia D, Guan XY, Said JW, Yang W, Fullwood MJ, Lin DC, Koeffler HP.
    Gastroenterology; 2020 Oct 01; 159(4):1311-1327.e19. PubMed ID: 32619460
    [Abstract] [Full Text] [Related]

  • 17. Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
    Liu X, Song M, Wang P, Zhao R, Chen H, Zhang M, Shi Y, Liu K, Liu F, Yang R, Li E, Bode AM, Dong Z, Lee MH.
    Int J Cancer; 2019 Aug 15; 145(4):1007-1019. PubMed ID: 30887517
    [Abstract] [Full Text] [Related]

  • 18. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells.
    Fu S, Jin L, Gong T, Pan S, Zheng S, Zhang X, Yang T, Sun Y, Wang Y, Guo J, Hui B, Zhang X.
    Oncol Rep; 2018 Apr 15; 39(4):1601-1608. PubMed ID: 29393484
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
    Hou G, Zhao Q, Zhang M, Fan T, Liu M, Shi X, Ren Y, Wang Y, Zhou J, Lu Z.
    Biomed Pharmacother; 2018 Oct 15; 106():1348-1356. PubMed ID: 30119206
    [Abstract] [Full Text] [Related]

  • 20. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma.
    Zhu Y, Yuan T, Zhang Y, Shi J, Bai L, Duan X, Tong R, Zhong L.
    Drug Des Devel Ther; 2019 Oct 15; 13():4321-4330. PubMed ID: 31908417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.